Latest Data


« Join The Fight Against Cancer Cannabis Compound May Stop Metastatic Breast Cancer (healthday) | Main | Topic Nexavar Approved For Liver Cancer (healthday) »

Join The Fight Against Cancer Elevated Interleukin-12 Is A Plasma Marker Of Poor Prognosis In Stage Iii Melanoma Patients

By admin2 | April 27, 2008

MedicalNew research has established that elevated blood levels of interleukin-12, which rise as we age, independently predicts poor prognosis in patients with melanoma. Interleukin-12 is a biological therapeutic agent that has been shown to act on the immune system and increase the body’s ability to fight disease.
(Link)

This entry was important to me: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • StumbleUpon
  • Digg
  • del.icio.us
  • Reddit
  • Furl
  • Junipo

Topics: Cancer |

Comments